According to its developers, the approach will aid studies of RNA regulation and how RNA localization is linked to biological processes and disease states.
A human-Neanderthal admixture event likely occurred before East Asian and European lineages diverged, while later events involved only East Asian or European lineages.
Genome-wide association and meta-analyses have uncovered a dozen ADHD-related loci, providing insights into its biology and overlap with other conditions.
Investigators published an initial report on the method, which they call cfMeDIP-Seq, last week, and are now hoping to move to analysis of samples from longitudinal health studies.
Distinct alterations of the APP gene in Alzheimer's patients appear to depend on reverse transcriptase, suggesting HIV antiretroviral drugs as a potential new treatment.
The researchers are using mass spectrometry to look in patient blood samples for peptides shed by Borrelia burgdorferi, the bacteria that causes Lyme disease.
A gene-environment analysis involving 10,346 twins suggests parents are more restrictive when feeding children who have a genetic propensity for weight gain.
Researchers at the University of Copenhagen used mass spectrometry to analyze dental plaque from 21 individuals recovered from a medieval Danish gravesite.
With sequence data for 910 African individuals, researchers found more than 296 million bases of sequence not represented in the human reference genome GRCh38.
A study presented at the National Society of Genetic Counselors annual meeting last week analyzed how counseling sessions affected patients on five measures.
Nashville Biosciences will offer access to BioVU, Vanderbilt University Medical Center's collection of DNA samples and patient records, through BC Platforms' solution.
The approach allows scientists to look at single amino acid variants linked to diseases like cancer and could aid the investigation of tumor heterogeneity.
A Georgia Tech team found that the reliance of genome-wide association studies on European populations has skewed estimates of disease risk in other populations.
The parties will test and implement BioLegend's TotalSeq antibodies as part of a workflow combing single-cell proteomics with single-cell transcriptomics.
